Physician profile
Debra Jemison
NPI 1508800400
$9,746.92
in general payments reported to CMS, 2019-2025
18 companies · $1,343 in 2025
The $1,343 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $249 · 2022: $609 · 2023: $202 · 2024: $7,344 · 2025: $1,343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,715 · Travel and Lodging: $1,850 · Long Term Medical Supply Or Device Loan: $1,231 · Food and Beverage: $1,018 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,715.00 |
| Travel and Lodging | $1,850.02 |
| Long Term Medical Supply Or Device Loan | $1,230.62 |
| Food and Beverage | $1,018.40 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $6,719.48 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $1,568.20 | 2021-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $446.74 | 2021-2023 | Imbruvica, Epkinly |
| Astrazeneca Pharmaceuticals LP | $250.00 | 2024-2025 | Imfinzi |
| Gilead Sciences, INC. | $136.36 | 2022-2023 | Trodelvy |
| Abbvie INC. | $123.95 | 2025 | |
| Amgen INC. | $99.95 | 2021 | |
| Aveo Pharmaceuticals, INC. | $93.49 | 2022 | |
| Incyte Corporation | $74.99 | 2024 | |
| Puma Biotechnology, INC. | $61.01 | 2025 | |
| Emd Serono, INC. | $33.18 | 2022 | |
| Lilly USA, LLC | $30.62 | 2021 | |
| Genzyme Corporation | $26.02 | 2024 | |
| Myovant Sciences INC. | $24.32 | 2021 | |
| Seagen INC. | $22.00 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $14.44 | 2022 | |
| Acrotech Biopharma INC. | $13.93 | 2021 | |
| Secura Bio, INC. | $8.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Jemison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.